(Q51372570)

4 April 2018

title

18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. (English)

1 reference

4 April 2018

1 reference

Glick SD

1

1 reference

4 April 2018

Maisonneuve IM

series ordinal

2

1 reference

4 April 2018

Szumlinski KK

series ordinal

3

1 reference

4 April 2018

language of work or name

English

0 references

publication date

1 September 2000

1 reference

4 April 2018

Annals of the New York Academy of Sciences

published in

1 reference

4 April 2018

volume

914

1 reference

4 April 2018

page(s)

369-386

1 reference

4 April 2018

Effects and aftereffects of ibogaine on morphine self-administration in rats

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Inhibitory effects of ibogaine on cocaine self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Ibogaine reduces preference for cocaine consumption in C57BL/6By mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Attenuation of alcohol intake by ibogaine in three strains of alcohol-preferring rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

A preliminary investigation of ibogaine: case reports and recommendations for further study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Tissue distribution of ibogaine after intraperitoneal and subcutaneous administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Sex differences in ibogaine antagonism of morphine-induced locomotor activity and in ibogaine brain levels and metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Effects of ibogaine on acute signs of morphine withdrawal in rats: independence from tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Ibogaine neurotoxicity: a re-evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

The neural basis of drug craving: an incentive-sensitization theory of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

A role for sensitization in craving and relapse in cocaine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Interactions between ibogaine and cocaine in rats: in vivo microdialysis and motor behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Time-dependent interactions between iboga agents and cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Ibogaine enhances the expression of locomotor sensitization in rats chronically treated with cocaine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Interaction of ibogaine and d-amphetamine: in vivo microdialysis and motor behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Ibogaine effects on sweet preference and amphetamine induced locomotion: implications for drug addiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Prior morphine exposure enhances ibogaine antagonism of morphine-induced locomotor stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Drugs and Reinforcement Mechanisms: A Critical Review of the Catecholamine Theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Serotonin and dopamine sensitization in the nucleus accumbens, ventral tegmental area, and dorsal raphe nucleus following repeated cocaine administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Dopamine functions in appetitive and defensive behaviours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Prior morphine exposure enhances ibogaine antagonism of morphine-induced dopamine release in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Acute iboga alkaloid effects on extracellular serotonin (5-HT) levels in nucleus accumbens and striatum in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Mechanisms of Antiaddictive Actions of Ibogainea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Ibogaine selectively inhibits nicotinic receptor-mediated catecholamine release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Ibogaine-like effects of noribogaine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Radioligand-binding study of noribogaine, a likely metabolite of ibogaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Biological and behavioral responses to D-amphetamine, alone and in combination with the serotonin3 receptor antagonist ondansetron, in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

5-HT3 receptor antagonists block cocaine-induced locomotion via a PCPA-sensitive mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Blockade of the expression of sensitization and tolerance by ondansetron, a 5-HT3 receptor antagonist, administered during withdrawal from intermittent and continuous cocaine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Cocaine discrimination is attenuated by isradipine and CGS 10746B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Effects of ondansetron administration on opioid withdrawal syndrome observed in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Role of opioid antagonists in treating intravenous cocaine abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Kappa opioid inhibition of morphine and cocaine self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

Modulation of morphine-induced antinociception by ibogaine and noribogaine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB05211.X

10.1111/J.1749-6632.2000.TB05211.X

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018